Disfunción endotelial en trasplante renal

Nefrologia

Volumn 23, Issue SUPPL.4, 2003, Pages 52-58

  Crespo, M ^a   Campistol, Josep M ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878036587     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Disfunción endotelial (NO/ET) e hipertensión arterial. Aspectos fisiopatológicos y terapéuticos. Sociedad Española de Hipertensión. Liga Española para la lucha contra la Hipertensión Arterial, 1999.
2. Aleixandre de Artiñano MA, Ortega Mateo AI: Función y disfunción endotelial. Editorial Complutense. Enero, 2000.
3. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka L, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda L, Yasue H, Nakao K: Endothelial Nitric Oxide Synthase Gene Is Positively Associated With Essential Hypertension. Hypertension 32: 3-8, 1998.
4. Luscher TF: The Endothelium and Cardiovascular Disease. A Complex Relation. N Engl J Med 330: 1081-1083, 1994.
5. Todd ME: Hypertensive structural changes in blood vessels: do endothelial cells hold the key? Can J Physiol Pharmacol 70(4): 536-551, 1992.
6. Wayne Alexander R: Hypertension and the Pathogenesis of Atherosclerosis Oxidative Stress and the Mediation of Arterial Inflammatory Response: a New Perspective. Hypertension 25: 155-161, 1995.
7. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM: Preserved EndotheliumDependent Vasodilatation in Patients with Essential Hypertension. N Engl J Med 330: 1036-1040, 1994.
8. Sharifi AM, LI JS, Endemann D, Schifffrin EL: Effects of enalapril and amlopdipine on small-artery structure and composition, and on endothelial dysfunction in spontaneosusly hyoertensive rats. J Hypertension 16(4): 457-465, 1998.
9. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
10. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
11. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.
12. Ignarro U, Byrns RE, Buga GM, Wood KS, Chaudhuri G: Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244: 181-189, 1988.
13. Murad F: The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent Prog Horm Res 49: 239-248, 1994.
14. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A: Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 18(7): 975-982, 1995.
15. Arcaro G, Zenere BM, Saggiani F, Zenti MG, Monauni T, Lechi A, Muggeo M, Bonadonna RC: ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria. Diabetes Care 22: 1536-1542, 1999.
16. Wardell K, Naver HK, Nilsson GE, Wallin BG: The cutaneous vascular axon reflex in humans characterized by laser Doppler perfusion imaging. J Physiol (Lond) 460: 185-199, 1993.
17. Asberg A, Midtvedt K, Vassbotn T, Hartmann A: Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. Nephrol Dial Transplant 16(7): 1465-1470, 2001.
18. Wilkinson IB, Cockcroft JR, Webb DJ: Pulse wave analysis and arterial stiffness. J Cardiovasc Pharmacol 32 (Supl. 1): S33-S37, 1998.
19. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE: Abnormal endothelium- dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323(1): 22-27, 1990.
20. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315(17):1046-1051, 1986.
21. Wilson RF, Laughlin DE, Ackell PH, Chilian WM, Holida MD, Hartley CJ, Armstrong ML, Marcus NIL, White CW: Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 72: 82-92, 1985.
22. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G: Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 342(7): 454-460, 2000.
23. Asberg A, Midtvedt K, Vassbotn T, Hartmann A: Better microvascular function on long-term treatment with lisinopril than with nifedipine in renal transplant recipients. Nephrol Dial Transplant 16(7): 1465-1470, 2001.
24. Hambrecht R, Fiehn E, Weigl C y cols.: Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98: 2709-2715, 1998.
25. Mulvany MJ, Halpern W: Mechanical properties of vascular smooth muscle cells in situ. Nature 260(5552): 617-619, 1976.
26. Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41: 19-26.
27. Mulvany MJ, Aalkjaer C: Structure and function of small arteries. Physiol Rev 70(4): 921-961, 1990.
28. Schiffrin EL, Deng LY, Larochelle: Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens 10(5): 437-44, 1992.
29. Goode GK, Heagerty AM: In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 91(12): 2898-903, 1995.
30. Falloon BJ, Stephens N, Tulip JR, Heagerty AM: Comparison of small artery sensitivity and morphology in pressurized and wired-mounted preparations. Am J Physiol 268(2 Pt 2): H670- 678, 1995.
31. Cecka JM: The UNOS Scientific Renal Transplant Registry. Clin Transpl 1-21, 1999.
32. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2; 342(9): 605-612, 2000.
33. Kasiske BL: Cardiovascular disease after renal transplantation. Semin Nephrol 20(2): 176-187, 2000.
34. Carter JT, Lee CM, Weinstein RJ, Lu AD, Dafoe DC, Alfrey EL: Evaluation of the older cadaveric kidney donor: the impact of donor hypertension and creatinine clearance on graft performance and survival. Transplantation 70(5): 765-771, 2000.
35. Kasiske BL, Klinger D: Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 11(4): 753-759, 2000.
36. Orida KN, Lai ChS: Nitric oxide and the renal patient. Dialysis & Transplantation 29(4): 174-186, 2000.
37. Aalkjaer C, Pedersen EB, Danielsen H, Fjeldborg O, Jespersen B, Kjaer T, Sorensen SS, Mulvany MJ: Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci (Colch) 71(6): 657-663, 1986.
38. Morris ST, McMurray JJ, Spiers A, Jardine AG: Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int 60(3): 1077-1082, 2001.
39. Robert W, Peter B, Hijmering M, Stroes E, Verhaar M, Kastelein J, Versluis K, Lagerwerf F, Van Rijn H, Koomans H, Rabelink T: Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 1168-1172, 1999.
40. DevIin J, Palmer RM, Gonde CE, O'Grady J, Heaton N, Tan KC, Martin JF, Moncada S, Williams R. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 58(5): 592-595, 1994.
41. Benvenuti C, Bories PN, Loisance D: Increased serum nitrate concentration in cardiac transplant patients. A marker for acute allograft cellular rejection. Transplantation 61(5): 745- 749, 1996.
42. Silkoff PE, Caramori M, Tremblay L, McClean P, Chaparro C, Kesten S, Hutcheon M, Slutsky AS, Zamel N, Keshavjee S: Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection. Am J Respir Crit Care Med 157(6 Pt 1): 1822-1828, 1998.
43. Casanova D, Martino E, Perojo I, Ramos C, Erce C, Rodriguez A, Salas E, Berrazueta JR, Amado A: Is the High Level of Nitric Oxide Metabolites a Marker in Early Rejection After Experimental Islet Pancreas Transplantation? Transplantation Proceedings 30 (2): 639-640, 1998.
44. Shannon D. Smith, Marcia A. Wheeler, Marc I, Lorber, Robert M: Weiss Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients. Kidney Int 58(2): 829-837, 2000.
45. Albrecht EW, Van Goor H, Tiebosch AT, Moshage H, Tegzess AM, Stegeman CA: Nitric oxide production and nitric oxide synthase expression in acute human renal allograft rejection. Transplantation 70(11): 1610-1616, 2000.
46. Romero M, García-Monzón C, Clemente G, Salcedo M, Álvarez E, Majano PL, Moreno-Otero R: Intrahepatic expression of inducible nitric oxide synthase in acute liver allograft rejection: evidence of modulation by corticosteroids. Liver Transpl Jan 7(1): 16-21, 2001.
47. Vos IH, Rabelink TJ, Dorland B, Loos R, Van Middelaar B, Grone HJ, Joles JA: Larginine supplementation improves function and reduces inflammation in renal allografts. J Am Soc Nephrol Feb; 12(2): 361-367, 2001.
48. Larry L, Shears II, Kawaharada N, Tzeng E, Billiar TR, Simon C, Watkins, Kovesdi I, Lizonova A, Si M: Pham. Inducible Nitric Oxide Synthase Suppresses the Development of Allograft Arteriosclerosis. J Clin Invest 100: 2035-2042, 1997.
49. Fukada J, Schena S, Tack I, Ruiz P, Kurimoto Y, Pang M, Aitouche A, Abe T, Striker LJ, Si M: Pharn FK409, a Spontaneous Nitric Oxide Releaser, Attenuates Allograft Vasculopathy in a Rat Aortic Transplant Model. Circulation Research 87: 66, 2000.
50. Hausberg M, Kisters K, Kosch M, Rahn KH, Barenbrock M: Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients. Kidney Int 55(3): 1104- 1110, 1999.
51. Vaskonen T, Mervaala E, Nevala R, Soots A, Krogerus L, Lahteenmaki T, Karppanen H, Vapaatalo H, Ahonen J: Development of chronic allograft rejection and arterial hypertension in Brown Norway rats after renal transplantation. Blood Press 9(2-3): 162-168, 2000.
52. Schrama YC, Van Dam T, Fijnheer R, Hene RJ, De Groot P, Rabelink TL: Cyclosporine is associated with endothelial dysfunction but not with platelet activation in renal transplantation. Neth J Med 59(1): 6-5, 2001.
53. Morris ST, McMurray JJ, Rodger RS, Farmer R, Jardine AG: Endothelial dysfunction in renal transplant recipients maintained on cyclosporine. Kidney Int 57 (3): 1100-1106, 2000.
54. Williams MJ, Sutherland WH, McCormick MP, De Jong SA, McDonald JR, Walker RJ: Vitamin C improves endothelial dysfunction in renal allograft recipients. Nephrol Dial Transplant 16 (6): 1251-1255, 2001.
55. Hausberg M, Kosch M, Stam F, Heidenreich S, Kisters K, Rahn KH, Barenbrock M: Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation. Kidney Int 59(4): 1473-1479, 2001.